What is driving the significant increase in Intuitive Surgical's revenue?

The substantial revenue growth is primarily driven by increased sales of the da Vinci Surgical System, including a higher number of system unit sales and fourth arm upgrades. Additionally, sales of instruments and accessories, along with service revenue, have seen significant increases due to a larger installed base of systems and higher utilization per site. The company also reports higher average selling prices for systems.

How is the company's profitability trending?

Intuitive Surgical is demonstrating improving profitability. Gross profit margins for both product sales (improving to 69.7% from 64.1%) and service sales (improving to 56.9% from 52.9%) have increased. This is attributed to better manufacturing cost leverage and higher average selling prices for products, as well as increased service revenue outgrowing the service organization expenses.

What is the outlook for operating expenses?

The company anticipates continued increases in operating expenses, particularly in Selling, General, and Administrative (SG&A) expenses, to support its expanding business and growth initiatives. Research and Development expenses are expected to continue to be substantial as the company invests in product development and enhancements.

What is the company's financial health and liquidity position?

Intuitive Surgical maintains a strong financial position. As of September 30, 2005, the company had $189.4 million in cash, cash equivalents, and short-term investments, up from $132.0 million at the end of 2004. Operating activities generated $44.1 million in cash for the nine months ended September 30, 2005, indicating healthy operational cash flow. The company believes its current resources are sufficient to meet its foreseeable liquidity needs.

ISRG 10-Q Quarterly Report Q3 FY2005 — Revenue, Net Income, EPS

Summary

Intuitive Surgical Inc. (ISRG) reported strong financial performance for the nine months ended September 30, 2005, demonstrating significant growth across key metrics. Total sales more than doubled compared to the same period in the prior year, driven by robust increases in both product and service revenues. The company's da Vinci Surgical System continues to gain market traction, evidenced by a substantial rise in system unit sales and a growing installed base, which in turn fuels recurring revenue from instruments, accessories, and service. The company exhibits improving profitability, with gross profit margins expanding for both product and service segments. Operating expenses also increased, largely due to investments in sales and marketing to support growth, but the company maintained operational efficiency. This robust top-line growth and margin expansion resulted in a significant increase in net income, more than tripling year-over-year for the nine-month period. The company ended the period with a strong liquidity position, ample cash and investments, and positive cash flow from operations, indicating a healthy financial foundation for future growth and product development.

Key Highlights

1Total sales surged by 68% year-over-year for the nine months ended September 30, 2005, reaching $155.2 million, indicating strong market demand.
2Product sales increased by 68% to $130.5 million, with system unit sales up significantly (75 systems shipped vs. 51 in prior year period) and a strong performance in instrument and accessory sales.
3Service revenue grew by 54% to $24.7 million, reflecting the expanding installed base of da Vinci Surgical Systems and higher service contract values.
4Gross profit margin for products improved to 69.7% from 64.1%, driven by higher ASPs and manufacturing leverage.
5Net income increased dramatically, growing from $11.8 million in the first nine months of 2004 to $44.6 million in the comparable 2005 period.
6The company maintained a healthy cash position, with cash, cash equivalents, and short-term investments totaling $189.4 million, supported by positive cash flow from operations.
7Selling, general, and administrative expenses increased by 36% to support sales growth, reflecting strategic investment in market expansion.

INTUITIVE SURGICAL INC Quarterly Report for Q3 Ended Sep 30, 2005

Summary

Key Highlights

Frequently Asked Questions